Celldex Therapeutics | CLDX - Ebit

Cena Akcji
33.29
Dzienna Zmiana
-0.26 -0.78%
Miesięcznie
5.08%
Rocznie
70.11%
Q2 Prognozy TE
33.79




Ebit Zmiana Data
AbbVie USD 5.81B 4.36B 2025-12
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.96B 464M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Northwest Biotherapeutics USD -14.32M 822K 2025-09
Pfizer USD 4.65B 71M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 9.56B 2.1B 2025-12